Yüklüyor......
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive change, with variants conferring advantage rapidly becoming dominant lineages, e.g., B.1.617. With apparent increased transmissibility, variant B.1.617.2 has contributed to the current wave of infection ravaging t...
Kaydedildi:
| Yayımlandı: | Cell |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cell Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8218332/ https://ncbi.nlm.nih.gov/pubmed/34242578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2021.06.020 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|